CRADLE: A RCT of CenteringPregnancy on Birth Outcomes

Sponsor
Clemson University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02640638
Collaborator
Prisma Health-Upstate (Other), University of California, Los Angeles (Other), Georgia State University (Other)
2,350
4
2
75.2
587.5
7.8

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate whether CenteringPregnancy group prenatal care can improve preterm birth rate and other birth outcomes, maternal psychosocial and behavioral outcomes, and decrease the racial difference in selected birth outcomes among African American and White women, compared to individual prenatal care.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CenteringPregnancy
N/A

Detailed Description

This is a randomized controlled trial to compare biomedical, behavioral and psychosocial outcomes by race among pregnant women who participate in CenteringPregnancy group prenatal care, to women in the traditional individual prenatal care and to investigate whether improving women's stress, activation and engagement will explain the potential benefits of CenteringPregnancy on outcomes and health disparities. The trial will be conducted in a large prenatal care center in South Carolina. Eligible White and Black women will be recruited before 20 weeks of gestational age with low risk pregnancy.

Study Design

Study Type:
Interventional
Actual Enrollment :
2350 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Reducing Disparities in Birth Outcomes: a Randomized Controlled Trial of CenteringPregnancy
Actual Study Start Date :
Feb 24, 2016
Actual Primary Completion Date :
Mar 31, 2020
Anticipated Study Completion Date :
May 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: CenteringPregnancy group prenatal care

Pregnant women who were randomized to receive CenteringPregnancy group prenatal care

Behavioral: CenteringPregnancy
8-12 pregnant women whose due dates are in the same month will receive ten 2-hour group prenatal care sessions according to the standard curriculum provided by the Centering Healthcare Institute.

No Intervention: Traditional individual prenatal care

Pregnant women who were randomized to receive traditional individual prenatal care

Outcome Measures

Primary Outcome Measures

  1. Preterm birth [Measured at delivery]

    Delivery before 37 weeks gestation

Secondary Outcome Measures

  1. Birth weight [Measured at delivery]

    Infant weight (in grams) a birth

  2. APGAR score [Measured at delivery]

    Five criteria used to summarize the health of newborn children: Appearance, Pulse, Grimace, Activity, Respiration

  3. Gestational weight gain [Measured at delivery]

    Weight gained during pregnancy as compared to medical recommendation

  4. Gestational diabetes incidence [Measured during pregnancy]

    Diabetes (occurred during pregnancy (two steps: 50-g GLT (nonfasting) with PG measurement at 1 h (Step 1), at 24-28 wks in women not previously diagnosed with overt diabetes If PG at 1 h after load is ≥140 mg/dL (7.8 mmol/L), proceed to 100-g OGTT (Step 2), performed while patient is fasting GDM diagnosis made when two or more PG levels meet or exceed: Fasting: 95 mg/dL or 105 mg/dL (5.3/5.8) hr: 180 mg/dL or 190 mg/dL (10.0/10.6) hr: 155 mg/dL or 165 mg/dL (8.6/9.2) hr: 140 mg/dL or 145 mg/dL (7.8/8.0)

  5. Gestational hypertension [Measured during pregnancy]

    Hypertension (SBP/DBP: above 140/90 mm Hg) occurred during pregnancy according to medical chart

  6. Patient activation measure [Measured at <20 week and 32-36 week of gestational age]

    Based on self-reported questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Pregnant women aged between 14-45 years

  2. Entry prenatal care before 20 6/7 weeks gestational age (defined as attendance at the intake screening visit). Patients must be randomized by 23 6/7 weeks gestational age.

Exclusion Criteria:
  1. Medical complications of pregnancy that would preclude prenatal care provision by nurse practitioners or participation in group care
  • Pregestational diabetes,

  • Severe chronic hypertension requiring medication,

  • Morbid Obesity with BMI >49.99

  • Renal disease with baseline proteinuria >1g/24 hours

  • Any disease requiring chronic immunosuppression (SLE, solid organ transplant)

  • Active pulmonary tuberculosis

  • Sickle cell anemia

  • Human Immunodeficiency Virus Infection

  • Other medical conditions that would exclude women from group care at the discretion of the PI

  1. Pregnancy complications that would preclude prenatal care provision by nurse practitioners or participation in group care
  • Multiple gestation

  • Lethal fetal anomalies

  • Other pregnancy complications that would exclude women from group care at the discretion of the PI

  1. Social and behavioral complications of pregnancy which would preclude prenatal care provision by nurse practitioners or participation in group care
  • Current incarceration

  • Severe psychiatric illness

Contacts and Locations

Locations

Site City State Country Postal Code
1 UCLA Los Angeles California United States 90095
2 Georgia State University Atlanta Georgia United States 30303
3 Clemson University Clemson South Carolina United States 29634-0745
4 Prisma Health Greenville South Carolina United States 29605

Sponsors and Collaborators

  • Clemson University
  • Prisma Health-Upstate
  • University of California, Los Angeles
  • Georgia State University

Investigators

  • Principal Investigator: Moonseong Heo, PhD, Clemson University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Moonseong Heo, Contact Principal Investigator, Clemson University
ClinicalTrials.gov Identifier:
NCT02640638
Other Study ID Numbers:
  • R01HD082311
First Posted:
Dec 29, 2015
Last Update Posted:
Aug 17, 2021
Last Verified:
Aug 1, 2021
Keywords provided by Moonseong Heo, Contact Principal Investigator, Clemson University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 17, 2021